Biohaven® is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including neuroscience, immunology and oncology. Our commitment to patients drives us to follow the path of science and motivates us to overcome the obstacles in bringing innovative medicines to those in need.
Latest Sponsored Posts
Epilepsy Patient Advocacy and the RISE Clinical Trial
RISE: A Clinical Trial For Epilepsy I recently had the opportunity to speak with Anne Neumann, RN, BSN, Rare Disease Marketing, Patient Advocacy and Engagement Lead at Biohaven, about her role and about RISE: A Clinical Trial For Epilepsy. Background on Ms. Neumann Anne brings over 25 years’ experience in healthcare, from … Read More
RISE: A Clinical Trial For Epilepsy I recently had the opportunity to speak with Jason Lerner, MD, Medical Director Research and Development at Biohaven, a board-certified pediatric neurologist and epileptologist about his role and about RISE: A Clinical Trial For Epilepsy. Background on Dr. Lerner Before joining Biohaven in the spring of … Read More